Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesThe role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders
Current Opinion in Clinical Nutrition & Metabolic Care, 10/27/09
Koopman R et al. – Multiple studies have identified anticachectic effects of beta–agonists and their therapeutic potential for pathologic states when muscle protein hypercatabolism is indicated. Future studies examining beta–agonist administration for muscle wasting conditions need to separate beneficial effects on skeletal muscle from potentially deleterious effects on the heart and cardiovascular system.
Related Articles
Regulation of Muscle Atrophy: Wasting Away from the Outside In: An Introduction
Medicine and Science in Sports and Exercise, 10/13/09
Relevance Score: 70%
Myostatin expression during human muscle hypertrophy and subsequent atrophy: increased myostatin with detraining
Scandinavian Journal of Medicine and Science in Sports, 11/17/09
Relevance Score: 69%
Vitamin D and its role in skeletal muscle
Current Opinion in Clinical Nutrition & Metabolic Care, 10/21/09
Relevance Score: 69%
Contribution of skeletal muscle mass on sex differences in 2-hour plasma glucose levels after oral glucose load in Thai subjects with normal glucose tolerance
Metabolism-Clinical and Experimental, 10/09/09
Relevance Score: 69%
Vitamin D and Human Skeletal Muscle
Scandinavian Journal of Medicine and Science in Sports, 10/09/09
Relevance Score: 69%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Antiretroviral Therapy With Heart
American Journal of Therapeutics, 11/25/09
Article Search
Sponsor